M. Tomirotti

1.7k total citations · 1 hit paper
32 papers, 904 citations indexed

About

M. Tomirotti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, M. Tomirotti has authored 32 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in M. Tomirotti's work include Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Vascular Tumors and Angiosarcomas (3 papers). M. Tomirotti is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Vascular Tumors and Angiosarcomas (3 papers). M. Tomirotti collaborates with scholars based in Italy, Switzerland and Ireland. M. Tomirotti's co-authors include A. Scanni, Gabriella Farina, Olga Martelli, Marina Chiara Garassino, Roberto Labianca, Calogero Lauricella, Massimo Broggini, Silvia Marsoni, Flavia Longo and Silvio Veronese and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.

In The Last Decade

M. Tomirotti

32 papers receiving 871 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial

2013 376 citations Marina Chiara Garassino, Olga Martelli et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Tomirotti Italy	14	539	498	140	95	93	32	904
Emanuele Naglieri Italy	15	200 0.4×	336 0.7×	210 1.5×	77 0.8×	180 1.9×	42	1.0k
B. Mennecier France	15	1.1k 2.0×	663 1.3×	241 1.7×	51 0.5×	25 0.3×	75	1.4k
Yun‐Gyoo Lee South Korea	15	430 0.8×	436 0.9×	233 1.7×	78 0.8×	17 0.2×	72	942
Suhong Luo United States	15	127 0.2×	300 0.6×	156 1.1×	120 1.3×	33 0.4×	65	899
Margot J. Burnell Canada	12	254 0.5×	649 1.3×	116 0.8×	141 1.5×	188 2.0×	32	1.1k
C. Tom Kouroukis Canada	18	151 0.3×	460 0.9×	252 1.8×	418 4.4×	19 0.2×	49	1.2k
Elrasheid A. H. Kheirelseid Ireland	15	232 0.4×	221 0.4×	287 2.0×	136 1.4×	122 1.3×	27	916
C.J. Cornell United States	11	119 0.2×	175 0.4×	233 1.7×	41 0.4×	44 0.5×	19	842
Renata D’Alpino Peixoto Brazil	17	320 0.6×	569 1.1×	119 0.8×	81 0.9×	15 0.2×	95	964
Laurence Venat‐Bouvet France	14	138 0.3×	366 0.7×	96 0.7×	45 0.5×	45 0.5×	40	647

Countries citing papers authored by M. Tomirotti

Since Specialization

Citations

This map shows the geographic impact of M. Tomirotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Tomirotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Tomirotti more than expected).

Fields of papers citing papers by M. Tomirotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Tomirotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Tomirotti. The network helps show where M. Tomirotti may publish in the future.

Co-authorship network of co-authors of M. Tomirotti

This figure shows the co-authorship network connecting the top 25 collaborators of M. Tomirotti. A scholar is included among the top collaborators of M. Tomirotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Tomirotti. M. Tomirotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

DeCensi, Andrea, Gianmauro Numico, Enzo Ballatori, et al.. (2018). Conflict of interest among Italian medical oncologists: a national survey. BMJ Open. 8(6). e020912–e020912. 5 indexed citations

Tomirotti, M., et al.. (2016). Analisi delle tendenze di lungo termine nel regime degli afflussi meteorici e dei deflussi dell’Adda a Lecco (1845-2014). Institutional Research Information System (Università degli Studi di Brescia). 1–4. 2 indexed citations

Lambertini, Matteo, Michela Cinquini, Ivan Moschetti, et al.. (2016). Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology. European Journal of Cancer. 71. 25–33. 65 indexed citations

Gullo, Giuseppe, Daniela Bettio, Monica Zuradelli, et al.. (2013). Level of HER2/neu amplification in primary tumours and metastases in HER2-positive breast cancer and survival after trastuzumab therapy. The Breast. 22(2). 190–193. 8 indexed citations

Garassino, Marina Chiara, Olga Martelli, Massimo Broggini, et al.. (2013). Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial. The Lancet Oncology. 14(10). 981–988. 376 indexed citations breakdown →

Bareggi, Claudia, Dario Consonni, Donatella Gambini, et al.. (2013). Uncommon Breast Malignancies: Presentation Pattern, Prognostic Issue and Treatment Outcome in an Italian Single Institution Experience. Tumori Journal. 99(1). 39–44. 1 indexed citations

Garassino, Marina Chiara, Olga Martelli, Anna Bettini, et al.. (2012). TAILOR: Phase III trial comparing erlotinib with docetaxel in the second-line treatment of NSCLC patients with wild-type (wt) EGFR.. Journal of Clinical Oncology. 30(15_suppl). LBA7501–LBA7501. 43 indexed citations

Garassino, Marina Chiara, Olga Martelli, Anna Bettini, et al.. (2012). TAILOR: A phase III trial comparing erlotinib with docetaxel as the second-line treatment of NSCLC patients with wild-type (wt) EGFR.. Journal of Clinical Oncology. 30(18_suppl). LBA7501–LBA7501. 22 indexed citations

Farina, Gabriella, Flavia Longo, Olga Martelli, et al.. (2011). Rationale for Treatment and Study Design of TAILOR: A Randomized Phase III Trial of Second-line Erlotinib Versus Docetaxel in the Treatment of Patients Affected by Advanced Non–Small-Cell Lung Cancer With the Absence of Epidermal Growth Factor Receptor Mutations. Clinical Lung Cancer. 12(2). 138–141. 13 indexed citations

10.

Gambini, Donatella, et al.. (2010). Paclitaxel-dependent prolonged and persistent complete remission four years from first recurrence of secondary breast angiosarcoma.. PubMed. 95(6). 828–31. 17 indexed citations

11.

Fagnani, Daniele, Alessandro Bertolini, Laura Catena, et al.. (2008). The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational study. Blood Coagulation & Fibrinolysis. 20(1). 35–40. 3 indexed citations

12.

Tomirotti, M.. (2002). Cancer and Pregnancy. Annals of Oncology. 13(1). 177–178. 5 indexed citations

13.

Ferreri, Andrés J.M., Michele Reni, Stefania Dell’Oro, et al.. (2001). Combined Treatment with High-Dose Methotrexate, Vincristine and Procarbazine, without Intrathecal Chemotherapy, Followed by Consolidation Radiotherapy for Primary Central Nervous System Lymphoma in Immunocompetent Patients. Oncology. 60(2). 134–140. 76 indexed citations

14.

Intra, Mattia, Andrea Pisani Ceretti, Mauro Pagani, et al.. (1999). Complications of Subcutaneous Infusion Port in the General Oncology Population. Oncology. 56(2). 97–102. 99 indexed citations

15.

Farina, Gabriella, et al.. (1997). Long Term Toxicity in Adjuvant Treatment with Tamoxifen. Journal of Chemotherapy. 9(4). 300–303. 2 indexed citations

16.

Tomirotti, M., et al.. (1994). Efficacy and tolerability of nasally administered compared to parenterally administered metoclopramide in the symptomatic treatment of chemotherapy-induced emesis in cancer outpatients A controlled clinical study. Supportive Care in Cancer. 2(6). 389–392. 6 indexed citations

17.

Tomirotti, M., et al.. (1988). Cisplatin (P) versus Cyclophosphamide, Adriamycin and Cisplatin (CAP) for Stage III-IV Epithelial Ovarian Carcinoma: A Prospective Randomized Trial. Tumori Journal. 74(5). 573–577. 13 indexed citations

18.

Tomirotti, M., et al.. (1985). Combination of Mitomycin C + Etoposide in Advanced Gastric Carcinoma. Tumori Journal. 71(4). 371–373. 1 indexed citations

19.

Scanni, A., et al.. (1979). Variations in Serum Copper and Ceruloplasmin Levels in Advanced Gastrointestinal Cancer Treated with Polychemotherapy. Tumori Journal. 65(3). 331–338. 15 indexed citations

20.

Scanni, A., et al.. (1977). Serum Copper and Ceruloplasmin Levels in Patients with Neoplasias Localized in the Stomach, Large Intestine or Lung. Tumori Journal. 63(2). 175–180. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact